Nitazoxanide Dosing by Weight
The recommended nitazoxanide dose is 7.5 mg/kg orally twice daily for children ages 1-3 years, 100 mg (5 mL) twice daily for children 4-11 years, and 500 mg twice daily for patients ≥12 years of age, all administered with food for 3 days. 1
Age-Based Dosing Algorithm
The FDA-approved dosing is stratified by age rather than strict weight-based calculations for most patients:
Pediatric Patients (1-11 years)
- Ages 1-3 years: 100 mg (5 mL of oral suspension) twice daily = approximately 7.5 mg/kg twice daily 2
- Ages 4-11 years: 200 mg (10 mL of oral suspension) twice daily 1
Adolescents and Adults (≥12 years)
- 500 mg twice daily (either tablets or 25 mL oral suspension) 1
Critical Administration Details
Always administer with food - this is non-negotiable. Food increases the AUC of the active metabolite (tizoxanide) by 45-50%, which is essential for therapeutic efficacy. 1 The clinical trials that established efficacy used food-accompanied administration, making this a requirement rather than a suggestion.
Treatment Duration
- Standard course: 3 days for both Giardia lamblia and Cryptosporidium parvum infections 1
- Dosing interval: Every 12 hours (twice daily) 1
Important Clinical Caveats
Formulation Restrictions
- Tablets contain too much drug for children ≤11 years - use oral suspension only in this age group 1
- A single 500 mg tablet exceeds recommended pediatric dosing
Population-Specific Limitations
- Not studied in infants <1 year of age - safety and efficacy unknown 1
- HIV-infected/immunodeficient patients: Not shown superior to placebo for C. parvum treatment; efficacy data for G. lamblia in this population is lacking 2, 1
- Renal/hepatic impairment: Pharmacokinetics unstudied - use with caution 1
Drug Interactions
Monitor closely when co-administering with highly protein-bound drugs with narrow therapeutic indices (e.g., warfarin), as tizoxanide is >99.9% protein-bound and may compete for binding sites 1
Comparative Efficacy Context
Research suggests nitazoxanide at 7.5 mg/kg twice daily for 3 days achieves approximately 78-84% parasitological cure rates for giardiasis 3, which is slightly lower than single-dose tinidazole (90.5%) but remains clinically acceptable. The drug is well-tolerated with only mild, self-limited side effects (primarily abdominal pain, headache, nausea) 1.